Toxicity Reducing and Efficacy Enhancing Effect of Shengfu Injection Combined with Tanreqing Injection on Chemotherapy of Advanced Lung Cancer with Spleen Deficiency and Phlegm Dampness Syndrome in Elderly Patients
|更新时间:2024-01-04
|
Toxicity Reducing and Efficacy Enhancing Effect of Shengfu Injection Combined with Tanreqing Injection on Chemotherapy of Advanced Lung Cancer with Spleen Deficiency and Phlegm Dampness Syndrome in Elderly Patients
Chinese Journal of Experimental Traditional Medical FormulaeVol. 24, Issue 14, Pages: 159-163(2018)
BAI Mao-shu, WANG Xi-cai, SUN Jiao, et al. Toxicity Reducing and Efficacy Enhancing Effect of Shengfu Injection Combined with Tanreqing Injection on Chemotherapy of Advanced Lung Cancer with Spleen Deficiency and Phlegm Dampness Syndrome in Elderly Patients[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(14): 159-163.
DOI:
BAI Mao-shu, WANG Xi-cai, SUN Jiao, et al. Toxicity Reducing and Efficacy Enhancing Effect of Shengfu Injection Combined with Tanreqing Injection on Chemotherapy of Advanced Lung Cancer with Spleen Deficiency and Phlegm Dampness Syndrome in Elderly Patients[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(14): 159-163. DOI: 10.13422/j.cnki.syfjx.20181319.
Toxicity Reducing and Efficacy Enhancing Effect of Shengfu Injection Combined with Tanreqing Injection on Chemotherapy of Advanced Lung Cancer with Spleen Deficiency and Phlegm Dampness Syndrome in Elderly Patients
Objective: To study the toxicity reducing and efficacy enhancing effect of Shengfu injection combined with Tanreqing injection on chemotherapy by supplementing Qi
warming Yang
resolving phlegm and detoxicating in elderly patients with advanced stage non-small cell lung cancer (NSCLC) of the wild type epithelial growth factor receptor(EGFR)after docetaxel chemotherapy. Method: The 64 eligible patients were divided into 2 groups equally:control group (docetaxel single drug chemotherapy regimen) and treatment group (Chinese medicine regimen with supplementing Qi
warming Yang
resolving phlegm and detoxicating effect based on the treatment in control group). All patients were injected with Docetaxel of 75 mg·m-2 by drip of each cycle in first day
and the patients in treatment group additionally received traditional Chinese medicine (TCM) regimen of Supplementing Qi
warming Yang
and detoxification effect (60-80 mL Shengfu injection was added to 250 mL 5% glucose injection for intravenous drip
qd
and 20-30 mL Tanreqing injection was added to 250 mL 5% glucose injection 250 mL
qd). The TCM regimen was given for 10 days. 21 days were regarded as 1 cycle
and the symptoms of Chinese medicine
immunologic function
Ⅲ-Ⅳ bone marrow suppression and safety were evaluated after 2 cycles' treatment. Result: The improvement of TCM symptoms (weak breath
hemoptysis
cough
expectorating phlegm
chest pain
chest tightness
et al) in the treatment group was better than that in control group
and the difference was statistically significant (P<0.05). After treatment
the peripheral blood CD3+
CD4+ and interleukin (IL)-27 of the treatment group were higher than those of control group (P<0.05)
and CD8+ and cytotoxic T lymphocyte associated antigen-4 (sCTLA-4) were lower than those of the control group (P<0.05)
with statistically significant difference (P<0.05). As compared with control group
the treatment group had a lower hematologic toxicity of grade Ⅲ/Ⅳ (P<0.05). Conclusion: Shengfu injection combined with Tanreqing injection with supplementing Qi
warming Yang
resolving phlegm and detoxicating effect can improve the TCM symptoms of advanced non-small cell lung cancer in elderly patients
increased the immune function of patients after chemotherapy